Evidence map›Paper›PMID 30271083›Full record

ArticleWorld journal of gastroenterology2018

Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.

Göksel Bengi, Hatice Keyvan, Seda Bayrak Durmaz, Hale Akpınar

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Göksel BengiDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, İzmir 35360, Turkey. goksel.bengi@deu.edu.tr.
Hatice KeyvanDepartment of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, İzmir 35360, Turkey.
Seda Bayrak DurmazDepartment of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, İzmir 35360, Turkey.
Hale AkpınarDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, İzmir 35360, Turkey.
Dokuz Eylül University · TRUniversity Gastroenterology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo specify the type and prevalence of anemia along with a treatment approach for inflammatory bowel disease (IBD).

methodsWe conducted a retrospective study on 465 patients who were diagnosed with IBD and followed up at our hospital from June 2015 to June 2016 [male: 254, female: 211; average age: 47 ± 14.4; Crohn's disease (CD): 257, Ulcerative Colitis (UC): 208]. Epidemiological and clinical data, such as sex, age, age of diagnosis, type of IBD, disease extension, disease behavior and duration, treatments for IBD and anemia, and surgical history were obtained for each patient. Per World Health Organization guidelines, anemia was diagnosed for males if hemoglobin values were less than 13 g/dL and for females if hemoglobin values were less than 12 g/dL.

resultsWe determined that 51.6% of the patients had anemia, which was more frequent in women then men (64%

conclusionWe found out that almost half of all IBD patients (51.6%) had anemia, the most frequent of which was IDA. Almost half of these patients received treatment. We should increase the treatment rate in our IBD patients that have anemia.

Indexed as

AdolescentAdultAgedAged, 80 and overAnemiaColitis, UlcerativeC-Reactive ProteinCrohn DiseaseFemaleGastrointestinal AgentsHematinicsHemoglobinsHumansMaleMiddle AgedPrevalenceC-Reactive ProteinGastrointestinal AgentsHematinicsHemoglobinsAnemiaAnemia of iron deficiencyInflammatory bowel disease

Identifiers

PMID30271083
PMCPMC6158484
OpenAlexW2893196866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.